Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro = Le tamoxifène et le 5-fluorouracile dans le cancer du sein: synergie cytotoxique in vitroBENZ, C; CADMAN, E; GWIN, J et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5298-5303, issn 0008-5472Article

Adsorption of tamoxifen and 2-methyl derivatives under cell culture conditionsCHAMART, S; HANOCQ, M; LECLERCQ, G et al.International journal of pharmaceutics. 1993, Vol 99, Num 1, pp 59-65, issn 0378-5173Article

Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communicationEBBS, S. R; ROBERTS, J; BAUM, M et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, issn 0022-4731, p. 239Conference Paper

An evaluation of tamoxifen as a partial agonist by classical receptor theory ― an explanation of the dual action of tamoxifenMACNAB, M. W; TALLARIDA, R. J; JOSEPH, R et al.European journal of pharmacology. 1984, Vol 103, Num 3-4, pp 321-326, issn 0014-2999Article

Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA = Le tamoxifène et le 5-fluorouracile dans le cancer du sein: modulation du RNA cellulaireBENZ, C; SANTOS, G; CADMAN, E et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5304-5308, issn 0008-5472Article

Effects of tamoxifen and levonorgestrel treatment on carbon tetrachloride induced alterations in ratsKULCSAR, A; KULCSAR-GERGELY, J.Arzneimittel-Forschung. 1991, Vol 41, Num 12, pp 1298-1301, issn 0004-4172Article

Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxytamoxifen introduced into liposomes. Similarity to cholesterol ang ergosterolWISEMAN, H; CANNON, M; ARNSTEIN, H. R. V et al.FEBS letters. 1990, Vol 274, Num 1-2, pp 107-110, issn 0014-5793Article

Treatment of oligozoospermia with tamoxifen (open and controlled studies)TOROK, L.Andrologia. 1985, Vol 17, Num 5, pp 497-501, issn 0303-4569Article

Über die Beeinflussung der Talgdrüsensekretion durch das Antiöstrogen Tamoxifen beim weiblichen und männlichen Goldhamster = Influence de l'antiœstrogène tamoxifène sur la sécrétion de la glande sébacée chez le hamster syrien femelle et mâle = The influence of the antiestrogen tamoxifen on the Sebaceous gland secretion in female and male golden syrian hamsterGLOOR, M; WIRTH, H; SCHLEIFER, K et al.H + G. Zeitschrift für Hautkrankheiten. 1983, Vol 58, Num 17, pp 1242-1247, issn 0301-0481Article

Tamoxifen decreases human prostate CPK concentrationGELLER, J; ALBERT, J. D; KIRSHNER, M et al.The Prostate. 1985, Vol 7, Num 3, pp 283-285, issn 0270-4137Article

Tamoxifen in the treatment of male breast carcinoma = Le tamoxifène dans le traitement du cancer du sein chez l'hommeRIBEIRO, G. G.Clinical radiology. 1983, Vol 34, Num 6, pp 625-628, issn 0009-9260Article

ANTIESTROGEN SPECIFIC, HIGH AFFINITY SATURABLE BINDING SITES IN RAT UTERINE CYTOSOLFAYE JC; LASSERRE B; BAYARD F et al.1980; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1980; VOL. 93; NO 4; PP. 1225-1231; BIBL. 13 REF.Article

Sensitivity and insensitivity of breast cancer to tamoxifenGIBSON, D. F. C; GOTTARDIS, M. M; JORDAN, V. C et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 765-770, issn 0960-0760, 6 p.Conference Paper

Microbial transformation of tamoxifenEL-SHARKAWY, S; ABUL-HAJJ, Y. J.Pharmaceutical research. 1987, Vol 4, Num 4, pp 353-354, issn 0724-8741Article

Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonographyFERRAZZI, Enrico; LEONE, F. P. G.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2004, Vol 18, Num 1, pp 145-156, issn 1521-6934, 12 p.Article

Antioestrogens in the management of hormone-dependent cancerLITHERLAND, S; JACKSON, I. M.Cancer treatment reviews. 1988, Vol 15, Num 3, pp 183-194, issn 0305-7372Article

Trans-4-hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breastMAUVAIS-JARVIS, P; BAUDOT, N; CASTAIGNE, D et al.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1521-1525, issn 0008-5472Article

Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifeneTIITINEN, Aila; NIKANDER, Eini; HIETANEN, Päivi et al.Maturitas (Amsterdam). 2004, Vol 48, Num 3, pp 321-327, issn 0378-5122, 7 p.Article

Involvement of PKA and Sp1 in the induction of p27^Kip1 by tamoxifenLEE, Te-Hsiu; CHANG, Hui-Chiu; CHUANG, Lea-Yea et al.Biochemical pharmacology. 2003, Vol 66, Num 3, pp 371-377, issn 0006-2952, 7 p.Article

In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifenLÖSER, R; SEIBEL, K; ROOS, W et al.European journal of cancer & clinical oncology. 1985, Vol 21, Num 8, pp 985-990, issn 0277-5379Article

TAMOXIFEN TREATMENT INDUCES PROTECTION IN MURINE CYSTICERCOSISVARGAS-VILLAVICENCIO, J. Antonio; LARRALDE, Carlos; DE LEON-NAVA, Marco A et al.The Journal of parasitology. 2007, Vol 93, Num 6, pp 1512-1517, issn 0022-3395, 6 p.Article

Amelioration of postmenopausal primary hyperparathyroidism during adjuvant tamoxifen for breast cancerKRISTENSEN, B; MOURIDSEN, H. T; HOLMEGAARD, S. N et al.Cancer. 1989, Vol 64, Num 9, pp 1965-1967, issn 0008-543X, 3 p.Article

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. WalpaleJORDAN, V. C.Breast cancer research and treatment. 1988, Vol 11, Num 3, pp 197-209, issn 0167-6806Article

Tamoxifen therapy of metastatic breast cancerMANNI, A.The Journal of laboratory and clinical medicine. 1987, Vol 109, Num 3, pp 290-299, issn 0022-2143Article

Response of multicentric desmoid tumours to tamoxifenPROCTER, H; SINGH, L; BAUM, M et al.British journal of surgery. 1987, Vol 74, Num 5, issn 0007-1323, 401Article